https://www.syriatechnologydigest.com/article/871861886-jasper-therapeutics-reports-positive-preliminary-data-from-etesian-study-of-briquilimab-in-asthma-and-findings-from-beacon-study-internal
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma...
https://www.consultantlive.com/view/beacon-positive-results-announced-briquilimab-chronic-spontaneous-urticaria
BEACON: Positive Results Announced for Briquilimab in Chronic Spontaneous Urticaria
Jasper Therapeutics has released new, positive findings on the use of briquilimab, a novel antibody therapy targeting KIT (CD117), in patients with CSU.
positive resultsbeaconannouncedbriquilimabchronic
https://kentuckyhealthwire.com/article/871861886-jasper-therapeutics-reports-positive-preliminary-data-from-etesian-study-of-briquilimab-in-asthma-and-findings-from-beacon-study-internal
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma...
https://www.technologyjournalohio.com/article/871861886-jasper-therapeutics-reports-positive-preliminary-data-from-etesian-study-of-briquilimab-in-asthma-and-findings-from-beacon-study-internal
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma...